Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akero Therapeutics, Inc. | 3,954,858 | reported | 24 Jun 2019 | tx 5+3,954,858−11,389,404 |
| Checkmate Pharmaceuticals, Inc. | 2,535,158 | reported | 04 May 2022 | tx 11+3,673,374−25,716,383 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 May 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 153,700 | 10.38 USD | |
| 03 May 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 79,475 | 10.37 USD | |
| 04 May 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 37,500 | 10.37 USD | |
| 20 Apr 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 85,611 | 10.39 USD | |
| 21 Apr 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 62,200 | 10.38 USD | |
| 19 Apr 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 399,923 | 10.42 USD | |
| 11 Aug 2020 | CONVERSION | Checkmate Pharmaceuticals, Inc. | 3,473,374 | — | |
| 11 Aug 2020 | PURCHASE | Checkmate Pharmaceuticals, Inc. | 200,000 | 15.00 USD | first after silence |
| 11 Aug 2020 | CONVERSION | Checkmate Pharmaceuticals, Inc. | 8,753,350 | 0.00 USD | deriv |
| 11 Aug 2020 | CONVERSION | Checkmate Pharmaceuticals, Inc. | 12,500,000 | 0.00 USD | deriv |
| 11 Aug 2020 | CONVERSION | Checkmate Pharmaceuticals, Inc. | 3,644,624 | 0.00 USD | deriv |
| 24 Jun 2019 | CONVERSION | Akero Therapeutics, Inc. | 3,469,759 | — | |
| 24 Jun 2019 | PURCHASE | Akero Therapeutics, Inc. | 250,000 | 16.00 USD | |
| 24 Jun 2019 | CONVERSION | Akero Therapeutics, Inc. | 235,099 | — | |
| 24 Jun 2019 | CONVERSION | Akero Therapeutics, Inc. | 722,737 | 0.00 USD | deriv |
| 24 Jun 2019 | CONVERSION | Akero Therapeutics, Inc. | 10,666,667 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 11 Aug 2020.